Neurocrine Biosciences Inc
Neurocrine Biosciences Reports Third-Quarter 2026 Financial Results
Total Third-Quarter 2026 Revenue Grew 41% Year-Over-Year to $1.1 Billion
Company newsroom
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
1 releases
Company newsroom
NASDAQ:NBIX
1 releases
Total Third-Quarter 2026 Revenue Grew 41% Year-Over-Year to $1.1 Billion